FDA Approves Unknown Drug — RISING
On December 19, 2000, Rising received FDA approval for ANDA075725, marking a significant commercial entry into the market. This approval is expected to bolster the company’s revenue streams and intensify competition within the established segment.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day